We help you get
closer to your customers.

It's Tuesday, it must be Chennai

Early rise to get across Delhi to the domestic airport to catch a 6:30am flight to Chennai. The discount airline business has hit India in a big way. There’s Jet Airways - very efficient; Kingfisher Airlines - yes, they serve Kingfisher beer; and SpiceJet, offering Red Hot Fares – I’ll leave it to your imagination how the SpiceJet flight attendants are dressed…

Chennai is the name for the city once known as Madras. It’s on the southeast coast of India, and it is quickly becoming known for its entrepreneurs and fast-growing companies.

We came to meet the CEO and founder of a high-growth pharmaceutical firm. They have done extremely well in the generics market and are looking to develop and bring new branded products to the US market.

Don’t let the south Indian serenity fool you. This company’s track record is simply amazing, and they now have FDA-certified drug manufacturing plants scattered across India and China. Their strategy is comprehensive and their experience in getting quick FDA approval of new products for the US market is impressive.

Pharmaceutical firms in India originally built their business and soaring market cap developing generic drugs, but now with high quality manufacturing capabilities, ambitious new drug discovery teams, and a desire to move away from thin generic pricing margins, they are preparing to enter the US market with a portfolio of new branded products.

There is still amazing product innovation happening within the health care industry, but it’s not all happening in North America and Europe. Look for new Indian pharmaceutical products in the US market over the next 12-24 months, filling unmet needs among both physicians and patients. And watch out for innovative new marketing initiatives to help those new products establish awareness and interest quickly and decisively. It’s a different way to look at India, isn’t it?